Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander G G Turpie

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Journal of Clinical Pharmacology|June 14, 2011
Response to "Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban"Alexander G G Turpie
Expert Opinion on Pharmacotherapy|May 28, 2004
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapyAlexander G G Turpie
Arteriosclerosis, Thrombosis, and Vascular Biology|March 24, 2007
Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseasesAlexander G G Turpie
Vascular Health and Risk Management|February 28, 2007
Fondaparinux in the management of patients with ST-elevation acute myocardial infarctionAlexander G G Turpie
The American Journal of Managed Care|January 6, 2007
Burden of disease: medical and economic impact of acute coronary syndromesAlexander G G Turpie
Seminars in Thrombosis and Hemostasis|September 17, 2002
State of the art--a journey through the world of antithrombotic therapyAlexander G G Turpie
Seminars in Thrombosis and Hemostasis|June 20, 2002
Optimizing prophylaxis of venous thromboembolismAlexander G G Turpie
American Journal of Orthopedics (Belle Mead, N.J.)|December 5, 2002
Use of selective factor Xa inhibitors in special populationsAlexander G G Turpie
Expert Opinion on Drug Safety|July 14, 2005
The safety of fondaparinux for the prevention and treatment of venous thromboembolismAlexander G G Turpie
The New England Journal of Medicine|August 12, 2005
Multidetector-row computed tomography in suspected pulmonary embolismAlexander G G Turpie
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Journal of Clinical Pharmacology|June 14, 2011
Response to "Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban"Alexander G G Turpie
Expert Opinion on Pharmacotherapy|May 28, 2004
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapyAlexander G G Turpie
Arteriosclerosis, Thrombosis, and Vascular Biology|March 24, 2007
Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseasesAlexander G G Turpie
Vascular Health and Risk Management|February 28, 2007
Fondaparinux in the management of patients with ST-elevation acute myocardial infarctionAlexander G G Turpie
The American Journal of Managed Care|January 6, 2007
Burden of disease: medical and economic impact of acute coronary syndromesAlexander G G Turpie
Seminars in Thrombosis and Hemostasis|September 17, 2002
State of the art--a journey through the world of antithrombotic therapyAlexander G G Turpie
Seminars in Thrombosis and Hemostasis|June 20, 2002
Optimizing prophylaxis of venous thromboembolismAlexander G G Turpie
American Journal of Orthopedics (Belle Mead, N.J.)|December 5, 2002
Use of selective factor Xa inhibitors in special populationsAlexander G G Turpie
Expert Opinion on Drug Safety|July 14, 2005
The safety of fondaparinux for the prevention and treatment of venous thromboembolismAlexander G G Turpie
The New England Journal of Medicine|August 12, 2005
Multidetector-row computed tomography in suspected pulmonary embolismAlexander G G Turpie
Pageof 18